NCT01435863 2015-08-13
A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL)
Solasia Pharma K.K.
Phase 1 Completed
Clinical Trials
5 trialsNCT01689220 2014-09-04
A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in Korea
Solasia Pharma K.K.
Phase 1 Completed
NCT00592046 2012-07-19
A Phase I Trial of ZIO-101 in Hematologic Cancers
Alaunos Therapeutics
Phase 1 Completed
NCT00592163 2012-07-19
Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas
Alaunos Therapeutics
Phase 1 Unknown
NCT01139359 2012-07-19
Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma
Alaunos Therapeutics
Phase 1 Withdrawn